Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    "Chorioretinitis"
Show Display Options
Rank Status Study
1 Unknown  To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis
Condition: Chorioretinitis
Interventions: Drug: pyrimethamine-sulfadiazine + prednisolone;   Drug: Clindamycin+Dexamethasone
2 Completed Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis
Condition: Central Serous Chorioretinitis
Interventions: Drug: Spironolactone;   Drug: Placebo
3 Completed Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
Condition: Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection
Interventions: Other: Fluorescein angiography;   Other: Dilated fundus examination;   Biological: Toxoplasmosis serology;   Drug: Anti-toxoplasmosis treatment;   Drug: Anti-inflammatory treatments;   Other: Puncture in anterior chamber
4 Withdrawn Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Conditions: Hearing Loss;   Mental Retardation;   Microcephaly;   Chorioretinitis
Intervention:
5 Completed Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
Condition: Ocular Toxoplasmosis
Intervention: Drug: Trimethoprim-Sulfamethoxazole
6 Completed Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
Conditions: Birdshot Chorioretinopathy;   Cystoid Macular Edema;   Transient Partial Visual Loss
Interventions: Drug: interferon alpha 2a;   Drug: prednisone
7 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)

Study has passed its completion date and status has not been verified in more than two years.